30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Checkpoint Therapeutics Inc (CKPT)

Track

The most recent insider trading activity occurred on May 29, 2025, with a significant sell transaction by Fortress Biotech, Inc. Prior to this, in April 2025, the CEO and CFO also engaged in sell transactions. Overall, the recent transactions show a consistent pattern of selling by key executives and a major shareholder.
Stock chart
Ticker: CKPT Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Fortress Biotech, Inc.
1 sale — total 129,000 USD
Sale 29 May 2025
Value US$3,962,542.06 | Price 31.11 | Shares 33,730
Sale 2 Apr 2025
Value US$3,644,186.89 | Price 220.00 | Shares 6,525
Sale 1 Apr 2025
Value US$49,904.10 | Price 4.05 | Shares 12,322
Sale 10 Feb 2025
Value US$32,542.65 | Price 3.15 | Shares 10,331
Sale 7 Feb 2025
Value US$31,484.53 | Price 3.41 | Shares 9,233
Sale 6 Feb 2025
Value US$271,983.70 | Price 3.67 | Shares 74,110
Sale 19 Dec 2024
Value US$744,377.40 | Price 3.38 | Shares 220,230
Sale 18 Dec 2024
Value US$2,330,386.29 | Price 3.87 | Shares 602,167
Sale 18 Dec 2024
Value US$1,076,412.32 | Price 4.01 | Shares 268,432
Sale 26 Jun 2024
Value US$50,450.50 | Price 2.05 | Shares 24,610
Sale 26 Jun 2024
Value US$26,858.28 | Price 2.06 | Shares 13,038
Sale 28 Feb 2024
Value US$4,212.45 | Price 2.07 | Shares 2,035
Sale 28 Feb 2024
Value US$12,141.64 | Price 2.06 | Shares 5,894
Sale 1 Feb 2024
Value US$23,919.00 | Price 2.01 | Shares 11,900
Sale 1 Feb 2024
Value US$8,024.25 | Price 1.95 | Shares 4,115
Sale 2 Mar 2023
Value US$17,955.00 | Price 5.00 | Shares 3,591
Sale 2 Mar 2023
Value US$27,415.00 | Price 5.00 | Shares 5,483
Sale 27 Feb 2023
Value US$8,919.24 | Price 4.66 | Shares 1,914
Sale 27 Feb 2023
Value US$25,798.20 | Price 4.65 | Shares 5,548
Sale 1 Feb 2023
Value US$48,944.97 | Price 4.77 | Shares 10,261
Sale 1 Feb 2023
Value US$15,107.66 | Price 4.79 | Shares 3,154
Sale 10 Jan 2023
Value US$25,760.93 | Price 6.75 | Shares 3,817
Sale 10 Jan 2023
Value US$12,539.64 | Price 6.75 | Shares 1,858
Sale 23 Jun 2022
Value US$16,650.00 | Price 1.11 | Shares 15,000
Sale 22 Jun 2022
Value US$13,080.00 | Price 1.09 | Shares 12,000
Sale 21 Jun 2022
Value US$22,890.00 | Price 1.09 | Shares 21,000
Sale 17 Jun 2022
Value US$248,520.00 | Price 1.09 | Shares 228,000
Sale 13 Apr 2022
Value US$32,099.58 | Price 1.51 | Shares 21,258
Sale 5 Apr 2022
Value US$24,833.10 | Price 1.77 | Shares 14,030
Sale 4 Apr 2022
Value US$154,571.87 | Price 1.79 | Shares 86,353
Sale 10 Mar 2022
Value US$72,306.92 | Price 1.89 | Shares 38,197
Sale 1 Feb 2022
Value US$92,954.00 | Price 2.51 | Shares 37,063
Sale 5 Feb 2021
Value US$166,744.70 | Price 3.42 | Shares 48,790
Sale 4 Feb 2021
Value US$96,318.04 | Price 3.66 | Shares 26,320
Sale 4 Feb 2021
Value US$245,525.00 | Price 3.51 | Shares 70,000
Sale 22 Dec 2020
Value US$6,712.50 | Price 2.79 | Shares 2,406
Sale 21 May 2020
Value US$34,122.48 | Price 2.00 | Shares 17,104
Buy 20 Nov 2019
Value US$127,000.00 | Price 1.27 | Shares 100,000
Buy 9 Nov 2018
Value US$116,715.10 | Price 2.35 | Shares 49,666
Buy 8 Nov 2018
Value US$108,044.16 | Price 2.24 | Shares 48,234
Buy 7 Nov 2018
Value US$4,452.00 | Price 2.12 | Shares 2,100
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2025-06-03 2025-05-29 S Sale
0.5
Fortress Biotech, Inc.
Large shareholder
33,730 +3.2%
31.11
US$3,962,542 		33,730 +3.2% 31.11 US$3,962,542
2025-04-03 2025-04-02 S Sale
3.3
Oliviero James F III

CEO, President and Director

Executive Director
6,525 -5.8%
220.00
US$3,644,187 		6,525 -5.8% 220.00 US$3,644,187
2025-04-03 2025-04-01 S Sale
3.5
GRAY WILLIAM GARRETT

Chief Financial Officer

Officer
66,455 +31.2%
154.36
US$1,700,838 		66,455 +31.2% 154.36 US$1,700,838
2025-02-11 2025-02-10 S Sale
3.3
Oliviero James F III

CEO, President and Director

Executive Director
10,331 -0.3%
3.15
US$32,543 		10,331 -0.3% 3.15 US$32,543
2025-02-11 2025-02-07 S Sale
3.3
Oliviero James F III

CEO, President and Director

Executive Director
9,233 -0.2%
3.41
US$31,485 		9,233 -0.2% 3.41 US$31,485
2025-02-07 2025-02-06 S Sale
3.5
GRAY WILLIAM GARRETT

Chief Financial Officer

Officer
74,110 -4.8%
3.67
US$271,984 		74,110 -4.8% 3.67 US$271,984
2024-12-20 2024-12-19 S Sale
3.3
Oliviero James F III

CEO, President and Director

Executive Director
220,230 -6.4%
3.38
US$744,377 		220,230 -6.4% 3.38 US$744,377
2024-12-20 2024-12-18 S Sale
3.3
Oliviero James F III

CEO, President and Director

Executive Director
602,167 -15.0%
3.87
US$2,330,386 		602,167 -15.0% 3.87 US$2,330,386
2024-12-20 2024-12-18 S Sale
3.5
GRAY WILLIAM GARRETT

Chief Financial Officer

Officer
268,432 -20.6%
4.01
US$1,076,412 		268,432 -20.6% 4.01 US$1,076,412
2024-06-28 2024-06-26 S Sale
3.3
Oliviero James F III

CEO, President and Director

Executive Director
24,610 -1.2%
2.05
US$50,450 		24,610 -1.2% 2.05 US$50,450
2024-06-28 2024-06-26 S Sale
3.5
GRAY WILLIAM GARRETT

Chief Financial Officer

Officer
13,038 -1.9%
2.06
US$26,858 		13,038 -1.9% 2.06 US$26,858
2024-03-01 2024-02-28 S Sale
3.5
GRAY WILLIAM GARRETT

Chief Financial Officer

Officer
2,035 -1.4%
2.07
US$4,212 		2,035 -1.4% 2.07 US$4,212
2024-03-01 2024-02-28 S Sale
3.3
Oliviero James F III

CEO, President and Director

Executive Director
5,894 -1.7%
2.06
US$12,142 		5,894 -1.7% 2.06 US$12,142
2024-02-02 2024-02-01 S Sale
3.3
Oliviero James F III

CEO, President and Director

Executive Director
11,900 -3.1%
2.01
US$23,919 		11,900 -3.1% 2.01 US$23,919
2024-02-02 2024-02-01 S Sale
3.5
GRAY WILLIAM GARRETT

Chief Financial Officer

Officer
4,115 -2.7%
1.95
US$8,024 		4,115 -2.7% 1.95 US$8,024
2023-03-03 2023-03-02 S Sale
3.5
GRAY WILLIAM GARRETT

Chief Financial Officer

Officer
3,591 -6.5%
5.00
US$17,955 		3,591 -6.5% 5.00 US$17,955
2023-03-03 2023-03-02 S Sale
3.3
Oliviero James F III

CEO, President and Director

Executive Director
5,483 -3.7%
5.00
US$27,415 		5,483 -3.7% 5.00 US$27,415
2023-03-03 2023-02-27 S Sale
3.5
GRAY WILLIAM GARRETT

Chief Financial Officer

Officer
1,914 -3.9%
4.66
US$8,919 		1,914 -3.9% 4.66 US$8,919
2023-03-03 2023-02-27 S Sale
3.3
Oliviero James F III

CEO, President and Director

Executive Director
5,548 -4.0%
4.65
US$25,798 		5,548 -4.0% 4.65 US$25,798
2023-02-03 2023-02-01 S Sale
3.3
Oliviero James F III

CEO, President and Director

Executive Director
10,261 -5.3%
4.77
US$48,945 		10,261 -5.3% 4.77 US$48,945
2023-02-03 2023-02-01 S Sale
3.5
GRAY WILLIAM GARRETT

Chief Financial Officer

Officer
3,154 -6.0%
4.79
US$15,108 		3,154 -6.0% 4.79 US$15,108
2023-01-12 2023-01-10 S Sale
3.3
Oliviero James F III

CEO, President and Director

Executive Director
3,817 -1.9%
6.75
US$25,761 		3,817 -1.9% 6.75 US$25,761
2023-01-12 2023-01-10 S Sale
3.5
GRAY WILLIAM GARRETT

Chief Financial Officer

Officer
1,858 -3.4%
6.75
US$12,540 		1,858 -3.4% 6.75 US$12,540
2022-07-01 2022-06-23 S Sale
3.3
Oliviero James F III

CEO, President and Director

Executive Director
15,000 -0.6%
1.11
US$16,650 		15,000 -0.6% 1.11 US$16,650
2022-07-01 2022-06-22 S Sale
3.3
Oliviero James F III

CEO, President and Director

Executive Director
12,000 -0.5%
1.09
US$13,080 		12,000 -0.5% 1.09 US$13,080
2022-07-01 2022-06-21 S Sale
3.3
Oliviero James F III

CEO, President and Director

Executive Director
21,000 -0.8%
1.09
US$22,890 		21,000 -0.8% 1.09 US$22,890
2022-07-01 2022-06-17 S Sale
3.3
Oliviero James F III

CEO, President and Director

Executive Director
228,000 -8.0%
1.09
US$248,520 		228,000 -8.0% 1.09 US$248,520
2022-04-22 2022-04-13 S Sale
3.3
Oliviero James F III

CEO, President and Director

Executive Director
21,258 -0.7%
1.51
US$32,100 		21,258 -0.7% 1.51 US$32,100
2022-04-22 2022-04-05 S Sale
3.3
Oliviero James F III

CEO, President and Director

Executive Director
14,030 -0.5%
1.77
US$24,833 		14,030 -0.5% 1.77 US$24,833
2022-04-22 2022-04-04 S Sale
3.3
Oliviero James F III

CEO, President and Director

Executive Director
86,353 -2.9%
1.79
US$154,572 		86,353 -2.9% 1.79 US$154,572
2022-03-11 2022-03-10 S Sale
3.5
GRAY WILLIAM GARRETT

Chief Financial Officer

Officer
38,197 -6.6%
1.89
US$72,307 		38,197 -6.6% 1.89 US$72,307
2022-02-02 2022-02-01 S Sale
3.5
GRAY WILLIAM GARRETT

Chief Financial Officer

Officer
37,063 -6.0%
2.51
US$92,954 		37,063 -6.0% 2.51 US$92,954
2021-02-05 2021-02-05 S Sale
3.3
Oliviero James F III

CEO, President and Director

Executive Director
48,790 -1.5%
3.42
US$166,745 		48,790 -1.5% 3.42 US$166,745
2021-02-05 2021-02-04 S Sale
3.5
GRAY WILLIAM GARRETT

Chief Financial Officer

Officer
26,320 -5.2%
3.66
US$96,318 		26,320 -5.2% 3.66 US$96,318
2021-02-05 2021-02-04 S Sale
3.3
Oliviero James F III

CEO, President and Director

Executive Director
70,000 -2.1%
3.51
US$245,525 		70,000 -2.1% 3.51 US$245,525
2020-12-23 2020-12-22 S Sale
3.5
GRAY WILLIAM GARRETT

Chief Financial Officer

Officer
2,406 -0.7%
2.79
US$6,712 		2,406 -0.7% 2.79 US$6,712
2020-05-22 2020-05-21 S Sale
3.5
GRAY WILLIAM GARRETT

See Remarks

Officer
17,104 -4.5%
2.00
US$34,122 		17,104 -4.5% 2.00 US$34,122
2019-11-22 2019-11-20 B Purchase ROSENWALD LINDSAY A MD Non-Executive Director
100,000 +72.5%
1.27
US$127,000 		100,000 +72.5% 1.27 US$127,000
2018-11-13 2018-11-09 B Purchase ROSENWALD LINDSAY A MD Non-Executive Director
49,666 +64.7%
2.35
US$116,715 		49,666 +64.7% 2.35 US$116,715
2018-11-13 2018-11-08 B Purchase ROSENWALD LINDSAY A MD Non-Executive Director
48,234 +169.0%
2.24
US$108,044 		48,234 +169.0% 2.24 US$108,044
2018-11-13 2018-11-07 B Purchase ROSENWALD LINDSAY A MD Non-Executive Director
2,100 +7.9%
2.12
US$4,452 		2,100 +7.9% 2.12 US$4,452
Explore more

More insider trading research around Checkpoint Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America